CN105795424A - 一种辅助降血脂的制品及其制备方法 - Google Patents
一种辅助降血脂的制品及其制备方法 Download PDFInfo
- Publication number
- CN105795424A CN105795424A CN201610185635.2A CN201610185635A CN105795424A CN 105795424 A CN105795424 A CN 105795424A CN 201610185635 A CN201610185635 A CN 201610185635A CN 105795424 A CN105795424 A CN 105795424A
- Authority
- CN
- China
- Prior art keywords
- momordicae charantiae
- pine nut
- parts
- goods
- fructus momordicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 48
- 239000008280 blood Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 150000002632 lipids Chemical class 0.000 title abstract description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 33
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 33
- 241000018646 Pinus brutia Species 0.000 claims abstract description 33
- 239000002994 raw material Substances 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 27
- 239000006187 pill Substances 0.000 claims abstract description 5
- 239000008187 granular material Substances 0.000 claims abstract description 3
- 239000003826 tablet Substances 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 33
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 24
- 241000180649 Panax notoginseng Species 0.000 claims description 24
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 claims description 21
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 238000001816 cooling Methods 0.000 claims description 9
- 239000012467 final product Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 235000011837 pasties Nutrition 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 7
- 244000302512 Momordica charantia Species 0.000 abstract description 5
- 235000009811 Momordica charantia Nutrition 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 244000075850 Avena orientalis Species 0.000 abstract description 3
- 235000007319 Avena orientalis Nutrition 0.000 abstract description 3
- 235000017159 Crataegus pinnatifida Nutrition 0.000 abstract description 3
- 241000657480 Crataegus pinnatifida Species 0.000 abstract description 3
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 3
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 3
- 229940109850 royal jelly Drugs 0.000 abstract description 3
- 235000007466 Corylus avellana Nutrition 0.000 abstract description 2
- 240000003211 Corylus maxima Species 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 230000000050 nutritive effect Effects 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 description 33
- 241000256836 Apis Species 0.000 description 23
- 230000000694 effects Effects 0.000 description 18
- 239000000463 material Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 241000256844 Apis mellifera Species 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000723382 Corylus Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000007330 LDL Lipoproteins Human genes 0.000 description 3
- 108010007622 LDL Lipoproteins Proteins 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000001465 calcium Nutrition 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 102000015779 HDL Lipoproteins Human genes 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 2
- 235000018365 Momordica dioica Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- HXQHFNIKBKZGRP-URPRIDOGSA-N (5Z,9Z,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C\C=C/CC\C=C/CCCC(O)=O HXQHFNIKBKZGRP-URPRIDOGSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 240000005440 Corylus heterophylla Species 0.000 description 1
- 235000018257 Corylus heterophylla Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 240000005856 Lyophyllum decastes Species 0.000 description 1
- 235000013194 Lyophyllum decastes Nutrition 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical compound OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- PTPHDVKWAYIFRX-UHFFFAOYSA-N Palmatine Natural products C1C2=C(OC)C(OC)=CC=C2C=C2N1CCC1=C2C=C(OC)C(OC)=C1 PTPHDVKWAYIFRX-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 208000029785 Puerperal disease Diseases 0.000 description 1
- HXQHFNIKBKZGRP-UHFFFAOYSA-N Ranuncelin-saeure-methylester Natural products CCCCCC=CCC=CCCC=CCCCC(O)=O HXQHFNIKBKZGRP-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000009306 yunnan baiyao Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及食品保健技术领域,具体是一种辅助降血脂的制品,其由以下重量份原料组成:松仁20‑25份、榛子10‑15份、山楂20‑25份、三七粉5‑8份、苦瓜3‑5份、燕麦3‑5份和蜂王浆1‑2份;该制品可以做成速溶粉剂、片剂、颗粒剂、丸剂的任何一种剂型。本发明是以坚果为主要原料,与山楂、三七粉、苦瓜、燕麦和蜂王浆合理搭配,即营养又能辅助降血脂。
Description
技术领域
本发明涉及食品保健技术领域,具体是一种辅助降血脂的制品及其制备方法。
背景技术
正常人每升血清中血总胆固醇(TC)的含量应低于5.2mmol,每升血清中甘油三酯(TG)的含量应低于1.5mmol,每升血清中低密度脂蛋白(LDL)的含量应低于64mmol,高密度脂蛋白(HDL)的含量应高于0.9mmol。长期高血脂会导致血液粘稠,血管壁慢慢附着很多代谢物,血管壁弹性减少,同时血管的通血能力减弱,血液运输养分和氧气能力降低,很多器官得不到正常的营养和氧气供应,器官功能逐渐受损,最先受损的是血管较小的腺体器官,长期血脂高还会导致血液的内环境变坏,很多免疫细胞无法生存,慢慢消失,导致免疫力降低。
随着生活水平的提高,人们脂肪和热量的摄取量大幅提高,而运动量的减少导致肥胖、高血脂的人越来越多。采用中药降血脂可以避免使用西药带来的毒副作用,但现有治疗高血脂的中药存在药物组分多,配比复杂,成本高,疗程长,疗效差的问题。
因此,人们希望有一种既营养,又能辅助降低血脂的制品。
发明内容
本发明的目的是提供一种以坚果为原料,即营养又能辅助降低血脂的制品及其制备方法。
为了实现上述目的,本发明采用的技术方案为:
一种辅助降血脂的制品,由以下重量份原料组成:
松仁20-25份;
榛子10-15份;
山楂20-25份;
三七粉5-8份;
苦瓜3-5份;
燕麦3-5份;
蜂王浆1-2份。
辅助降血脂的制品可以做成速溶粉剂、片剂、颗粒剂、丸剂的任何一种剂型。
所述速溶粉剂的制备方法为:按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50-100目,将五种原料在混合机中加入三七粉充分混合后,加入蜂王浆,搅拌均匀,分装即得。
所述片剂和丸剂的制备方法:按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50-100目,将五种原料在混合机中加入三七粉和蜂王浆充分混合后,加入适量纯净水混合调成糊状,成形、干燥、分装,即得。
所述速溶颗粒的制备方法为:按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50-100目,将五种原料在混合机中加入三七粉和蜂王浆充分混合后,加入适量纯净水混合调成糊状,并加入蜂蜜,在搅拌机中混合10-15分钟,喷雾干燥、筛分、灭菌、分装,即得。
所述的松仁为松科植物红松的种子仁,中文名称:松子仁,又称松子、海松子等。味甘性温。松仁性温味甘,具有养阴、熄风、润肺、滑肠等功效,能治疗风痹、头眩、燥咳、吐血、便秘等病。松仁具有预防心血管病作用松仁所含的脂肪,主要为亚油酸和皮诺敛酸等多不饱和脂肪酸,可调整和降低血脂、软化血管和防治动脉粥样硬化。多不饱和脂肪酸还能减少血小板的凝集和增加抗凝作用,故能降低血脂和血液黏稠度,预防血栓形成,对心血管系统有保护作用,因此,老年人常食松籽,能防止因胆固醇增高而引起的心血管疾病。松仁具有滋阴润肺、养液滑肠、通便等作用。因其含有丰富的脂肪、棕榈碱、挥发油等,能润滑大肠而通便、缓泻且不伤正气,尤其适用于年老体弱、产后病后的大便秘结者。便秘可使有毒物质和致癌物等不能及时排出体外,而且人体内废物不能及时排出,还会影响皮肤的光洁、润泽,而变得粗糙。
所述的榛子,中文学名,榛子,英文名:filbert,二名法,CorylusheterophyllaFisch.exBess.Corylusheterop,又称山板栗、尖栗、棰子等,属桦木科(corylaceae)榛属(Corylus)植物。性味甘平,能补脾益气,涩肠止泻。《开宝本草》谓能“益气力,实肠胃,令人不饥,健行。”故性能极似栗子。但少用作补肾强腰的药物。可用于脾胃虚弱、少食乏力、便溏腹泻等。单用或与山药、白术、栗子等配伍。生嚼、熟食均可。但以熟食为好。榛子含有丰富的脂肪主要是人体不能自身合成的不饱和脂肪酸,一方面可以促进胆固醇的代谢,另一方面可以软化血管,维护毛细血管的健康,从而预防和治疗高血压、动脉硬化等心脑血管疾病。
所述的山楂,中文学名:山楂,拉丁学名:Crataeguspinnatifida,可食用植物,核果类水果,质硬,果肉薄,味微酸涩,山楂味酸性温,气血并走,化瘀而不伤新血,行滞气而不伤正气,应用于肉食积滞证,泻痢腹痛、疝气痛、瘀滞腹痛胸痛、恶露不尽、痛经、吐血、便血等。现代单用本品制剂治疗心血管疾病、细菌性痢疾等,均有较好疗效。山楂主要含有黄酮类、低聚黄烷类、有机酸类、微量元素,另外还有含有三萜类、甾体类和有机胺类等成分。近几年来,山楂在降血脂、降血压、抗脑血及其作用机制方面取得了重大进展。
所述的三七粉,学名:Panaxpseudo-ginseng,是植物三七的根茎制品。是云南白药的主要成分。主产地在中国的云南及广西深山中,性温,味甘微苦,入肝、胃、大肠经。三七粉的成分和三七主根一样,富含三七皂苷、三七多糖、三七素、黄酮有效成分,具有止血、活血化瘀、消肿定痛、滋补强壮、抗疲劳、耐缺氧、抗衰老、降血脂、降血糖、提高机体免疫功能等作用。
所述的苦瓜又名凉瓜,是葫芦科植物,为一年生攀缘草本。中文学名:苦瓜,拉丁学名:MomordicacharantiaLinn.,别名:凉瓜,赖葡萄,锦荔枝,菩提瓜。性味:寒,苦。功用:清热解暑,明目解毒。苦瓜气味苦、无毒、性寒,入心、肝、脾、肺经具有清暑解渴、降血压、血脂,主治中暑、暑热烦渴、暑疖、痱子过多、痢疾、疮肿、结膜炎、目赤肿痛、痈肿丹毒、烧烫伤、少尿等病症。另外,苦瓜的维生素C含量很高,具有预防坏血病、保护细胞膜、防止动脉粥样硬化、提高机体应激能力、保护心脏等作用苦瓜里面含有一种成分,可以有效抑制正常一包的癌变和促进特变细胞的复原,具有一定的抗癌作用,而且还具备有降血脂和血压的特点。不仅如此,苦瓜还有预防骨质疏松、调节内分泌、抗氧化等作用,同时进一步提高人体抵抗力,提高身体里面的反应机制。
所述的燕麦,(学名:Avenasativa)富含淀粉、蛋白质、脂肪、B族维生素、尼克酸、叶酸、泛酸、钙、铁等营养成分,具有益肝和胃、养颜护肤等功效。此外,它还可以改善血液循环、缓解生活工作带来的压力;含有的钙、磷、铁、锌等矿物质也有预防骨质疏松、促进伤口愈合、预防贫血的功效,是补钙极品。而且,燕麦中极其丰富的亚油酸,对老年人增强体力,延年益寿也是大有禆益的。
所述的蜂王浆,外文名称:royaljelly,又称蜂皇浆、蜂王乳等,是工蜂的一种分泌物,喂蜂后的食物。初出生的蜂王幼虫,吃了蜂王浆,便会发育成为蜂后,否则就会发育成为工蜂。部份人认为蜂王浆有食疗功效,并将之视为营养补充剂。部份人则认为没有确凿的证据表明其能治疗任何疾病,有导致过敏的危险,并认为蜂王浆是一种很“神奇的”食物,但也只是针对蜜蜂王国而言。蜂王浆含有人体必须的维生素达10种以上,能平衡脂肪代谢和糖代谢,可降低肥胖者的高血脂和高血糖,非常适合肥胖型糖尿病患者。长期服用蜂王浆对三脂异常症、血管硬化、心律不齐、糖尿病等疾病患者均有很好的疗效。
本发明辅助降血脂的制品的有益效果为:
1、本辅助降血脂制品,以坚果为主要原料,与山楂、三七粉、苦瓜、燕麦和蜂王浆合理搭配,即营养又能辅助降血脂,不会加重血管负担。
2、使用方便,该制品可以开水冲开稍凉后服用,容易被人体消化吸收,无毒副作用。
3、原料中添加蜂王浆,蜂王浆对三脂异常症、血管硬化、心律不齐、糖尿病等疾病患者均有很好的疗效。
具体实施方式
为了更加详细的介绍本发明,下面结合实施例,对本发明做进一步的说明。
实施例1辅助降血脂的制品粉剂配方
取以下重量份原料:松仁20份、榛子10份、山楂20份、三七粉5份、苦瓜3份、燕麦3份和蜂王浆1份。
制备方法,按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50目,将五种原料在混合机中加入三七粉充分混合后,加入蜂王浆,搅拌均匀,分装20克每袋,即得。
实施例2辅助降血脂的制品片剂和丸剂配方
取以下重量份原料:松仁22份、榛子13份、山楂23份、三七粉6份、苦瓜4份、燕麦4份和蜂王浆1份。
制备方法,按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成80目,将五种原料在混合机中加入三七粉和蜂王浆充分混合后,加入适量纯净水混合调成糊状,成形、干燥、分装25克,即得。
实施例3辅助降血脂的制品颗粒剂配方
取以下重量份原料:松仁25份、榛子15份、山楂25份、三七粉8份、苦瓜5份、燕麦5份和蜂王浆2份。
制备方法,按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成100目,将五种原料在混合机中加入三七粉和蜂王浆充分混合后,加入适量纯净水混合调成糊状,并加入蜂蜜,在搅拌机中混合15分钟,喷雾干燥、筛分、灭菌、分装30克每袋,即得。
本发明所采用的原料,是本发明人进行长时间的研究得到的。本发明所采用的原料是最优的组合。
研究过程发现:采用原料组份1-4的任意一种,所得到的降血脂效果都没有本发明采用的原料组份效果好。采用原料组份1-4的任意一种,它们都具有降血脂的效果,但效果不是很明显;而采用本发明的原料组份降血脂的效果好,且营养,服用后皮肤变得红润。
原料组份1:榛子10-15份、山楂20-25份、三七粉5-8份、苦瓜3-5份、燕麦3-5份和蜂王浆1-2份。
原料组份2:松仁20-25份、山楂20-25份、三七粉5-8份、苦瓜3-5份、燕麦3-5份和蜂王浆1-2份。
原料组份3:松仁20-25份、榛子10-15份、三七粉5-8份、苦瓜3-5份和燕麦3-5份。
原料组份4:松仁20-25份、山楂20-25份、三七粉5-8份、苦瓜3-5份和燕麦3-5份。
上述实施例的产品提供给20例30-65岁的血脂高的人群服用,原来经常头晕目眩、胸闷,服用本发明辅助降血脂的制品粉剂,1个月后头晕目眩和胸闷的症状减轻,20例实验者有16例35天后,头晕目眩和胸闷的症状改善,血脂恢复正常值,有效率80%。
应用实施例
1、广西南宁黄某某,男,30岁,大学毕业工作已6年,黄某某毕业后,很少运动,除了应酬外,基本上都是公司和宿舍两点一线,且他喜欢吃炸薯条和炸鸡翅等高热量的食品,工作三年已经长了40多斤。在一次工作体检中,发现自己的血脂偏高,因此,他控制了饮食,有空偶尔也运动运动,但工作忙没有能坚持,血脂也没有降下来。无意中在朋友处了解了该制品,他买了一大包,每天用30-50克开水冲开后服用,当想吃零食时就用开水冲开服用,服用半个月后,血脂已降低到接近正常值,一个月后,血脂恢复到正常值。
Claims (5)
1.一种辅助降血脂的制品,其特征在于:由以下重量份原料组成:松仁20-25份、榛子10-15份、山楂20-25份、三七粉5-8份、苦瓜3-5份、燕麦3-5份和蜂王浆1-2份。
2.根据权利要求1所述的辅助降血脂的制品,其特征在于:该制品可以做成速溶粉剂、片剂、颗粒剂、丸剂的任何一种剂型。
3.根据权利要求2所述的辅助降血脂的制品,其特征在于:所述速溶粉剂的制备方法为:按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50-100目,将五种原料在混合机中加入三七粉充分混合后,加入蜂王浆,搅拌均匀,分装即得。
4.根据权利要求2所述的辅助降血脂的制品,其特征在于:所述片剂和丸剂的制备方法:按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50-100目,将五种原料在混合机中加入三七粉和蜂王浆充分混合后,加入适量纯净水混合调成糊状,成形、干燥、分装,即得。
5.根据权利要求2所述的辅助降血脂的制品,其特征在于:所述速溶颗粒的制备方法为:按所述重量份称取原料,清水洗净,将苦瓜晒干,备用,将松仁和榛子煮熟或炒熟,冷却,备用;将松仁、榛子、山楂、苦瓜和燕麦磨成50-100目,将五种原料在混合机中加入三七粉和蜂王浆充分混合后,加入适量纯净水混合调成糊状,并加入蜂蜜,在搅拌机中混合10-15分钟,喷雾干燥、筛分、灭菌、分装,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610185635.2A CN105795424A (zh) | 2016-03-29 | 2016-03-29 | 一种辅助降血脂的制品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610185635.2A CN105795424A (zh) | 2016-03-29 | 2016-03-29 | 一种辅助降血脂的制品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105795424A true CN105795424A (zh) | 2016-07-27 |
Family
ID=56454968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610185635.2A Pending CN105795424A (zh) | 2016-03-29 | 2016-03-29 | 一种辅助降血脂的制品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105795424A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101530209A (zh) * | 2009-04-17 | 2009-09-16 | 同溢堂药业有限公司 | 一种调节血脂及护肝的保健食品及其制备方法 |
CN103859303A (zh) * | 2014-03-26 | 2014-06-18 | 安徽燕之坊食品有限公司 | 一种坚果粗粮脆食品及其制备方法 |
CN104473173A (zh) * | 2015-01-04 | 2015-04-01 | 山东大学(威海) | 预防中老年心血管疾病的保健食品及其制备方法 |
-
2016
- 2016-03-29 CN CN201610185635.2A patent/CN105795424A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101530209A (zh) * | 2009-04-17 | 2009-09-16 | 同溢堂药业有限公司 | 一种调节血脂及护肝的保健食品及其制备方法 |
CN103859303A (zh) * | 2014-03-26 | 2014-06-18 | 安徽燕之坊食品有限公司 | 一种坚果粗粮脆食品及其制备方法 |
CN104473173A (zh) * | 2015-01-04 | 2015-04-01 | 山东大学(威海) | 预防中老年心血管疾病的保健食品及其制备方法 |
Non-Patent Citations (2)
Title |
---|
丁晓雯 等: "《保健食品原理》", 28 February 2008 * |
郑建仙: "《功能性食品学》", 30 June 2009, 中国轻工业出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107296949A (zh) | 药食同源复合制剂及其制备方法和应用 | |
KR101738912B1 (ko) | 비만억제 및 다이어트 조성물 | |
CN105851806A (zh) | 一种甲子米 | |
CN110447902B (zh) | 一种具有减肥功效的组合物 | |
CN104351795A (zh) | 一种辅助降血压代餐粉及其制备方法 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN102940153A (zh) | 一种改善肉质、蛋质的家禽饲料 | |
CN105925421B (zh) | 一种防治更年期综合征的金花葵保健酒及其制备方法 | |
CN107156363A (zh) | 一种具有减肥功效的复配茶及其制备方法 | |
CN103734392A (zh) | 火麻黑苦荞茶保健饮品及其制备方法 | |
KR101632794B1 (ko) | 흰점박이 꽃무지를 주재료로 하는 환의 제조방법 | |
CN105995399A (zh) | 调节人体亚健康的药膳粉 | |
CN106234822A (zh) | 蛋鸡产蛋期饲料及加工方法 | |
CN103168813A (zh) | 一种红景天苦荞饼干及其制作方法 | |
CN111110792A (zh) | 一种控糖调脂降粘防治糖尿病及其并发症的黄精人参茶 | |
KR20090127970A (ko) | 생식환의 조성물 및 이의 제조 방법 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN111771970A (zh) | 有助于养胃、护胃的组合物及其制备方法 | |
CN111387345A (zh) | 一种复合多糖组合物及其制备方法 | |
CN110638044A (zh) | 综合调理人体亚健康状态的素食代餐粉及其制备方法 | |
CN107397163B (zh) | 一种适合于肥胖人群的方便食品及其制备方法 | |
CN105815738A (zh) | 一种辅助降血糖的制品及其制备方法 | |
CN108186966A (zh) | 一种预防或改善老年痴呆症的组合物及其应用 | |
CN113367329A (zh) | 一种三米芩豆代餐粉及其制备方法 | |
CN105795424A (zh) | 一种辅助降血脂的制品及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160727 |
|
RJ01 | Rejection of invention patent application after publication |